DNA methylation analysis in MSC therapy

JRCT ID: jRCT1010220030

Registered date:23/12/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: brain injury etc
• Date of first enrollment: 23/12/2022
• Target sample size: 50
• Study type: Observational

Outcome(s)

• Primary Outcome: DNAge (DNAge Epigenetic Aging Clock)

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients newly admitted to Sapporo Medical University Hospital for the administration of MSCs who are able to obtain consent will be included. The scope of the study includes physician-initiated clinical trials using MSCs (STR01-01, STR01-02, STR01-03, STR01-04, STR01-05, and STR01-08 studies) and patients undergoing treatment with Stemilac Injection who are judged to be capable of safely obtaining blood samples. Subjects.

Exclude criteria

(1) Cases in which consent to participate in the research could not be obtained.
(2). cases in which it is considered difficult to collect specimens safely.

Related Information

• Primary Sponsor: Sasaki Masanori